386 related articles for article (PubMed ID: 8473213)
1. AVMA legislation: partial solution to drug availability problem.
Gloyd JS
J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
[No Abstract] [Full Text] [Related]
2. Current FDA policy on use of human-labeled drugs in animals.
Teske RH
J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
[No Abstract] [Full Text] [Related]
3. Controlling distribution of drugs.
Lane DM
J Am Vet Med Assoc; 1984 Oct; 185(7):722-3. PubMed ID: 6490498
[No Abstract] [Full Text] [Related]
4. Professional drug labeling.
Terry M
J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
[No Abstract] [Full Text] [Related]
5. Implications for the FDA/Center for Veterinary Medicine (CVM).
Geyer RE
J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
[No Abstract] [Full Text] [Related]
6. FDA extra-label use policy: 1992 revisions.
Guest GB; Solomon SM
J Am Vet Med Assoc; 1993 May; 202(10):1620-3;discussion 1626-31. PubMed ID: 8514568
[No Abstract] [Full Text] [Related]
7. Extra-label rules: the final outcome.
Curry-Galvin E
J Am Vet Med Assoc; 1997 Jan; 210(1):10-2. PubMed ID: 8977639
[No Abstract] [Full Text] [Related]
8. Compounding forum: FDA-CVM hears veterinarians' views.
J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690
[No Abstract] [Full Text] [Related]
9. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
Terry M
Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
[No Abstract] [Full Text] [Related]
10. [Off-label use and the 'explanation'].
Kamphuis A; de Groot SJ
Tijdschr Diergeneeskd; 2003 May; 128(10):340-1. PubMed ID: 12793041
[No Abstract] [Full Text] [Related]
11. Therapeutic orphans.
Shirkey H
Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
[No Abstract] [Full Text] [Related]
12. The AVMA legislative initiative: a legal overview.
Stribling JH
J Am Vet Med Assoc; 1993 May; 202(10):1671-4;discussion 1684-92. PubMed ID: 8514580
[No Abstract] [Full Text] [Related]
13. AVMA conveys concerns to CVM on dipyrone ban.
J Am Vet Med Assoc; 1996 Feb; 208(4):460. PubMed ID: 8603885
[No Abstract] [Full Text] [Related]
14. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
[No Abstract] [Full Text] [Related]
15. Separate manufacturing standards needed for veterinary drugs: AVMA.
J Am Vet Med Assoc; 1996 Feb; 208(4):461. PubMed ID: 8603886
[No Abstract] [Full Text] [Related]
16. Scientific basis for nonapproved use of drugs in veterinary practice.
Brumbaugh GW
J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
[No Abstract] [Full Text] [Related]
17. Is pediatric labeling really necessary?
Christensen ML; Helms RA; Chesney RW
Pediatrics; 1999 Sep; 104(3 Pt 2):593-7. PubMed ID: 10469796
[No Abstract] [Full Text] [Related]
18. Flexible labeling, streamlined drug approval advocated at workshop.
Raef TA
J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
[No Abstract] [Full Text] [Related]
19. Educating veterinarians to prescribe and use drugs in a responsible manner.
Jenkins WL
J Am Vet Med Assoc; 1993 May; 202(10):1708-10;discussion 1713-7. PubMed ID: 8514590
[No Abstract] [Full Text] [Related]
20. Who's to blame for inappropriate use of drugs?
Cobb DV
J Am Vet Med Assoc; 1998 Aug; 213(3):338-9. PubMed ID: 9702217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
